ABG SRNE Ltd, 10% Owner at Sorrento Therapeutics, Inc. (SRNE), bought 2,500,000 shares at $2.00 ($5.0M) on 2017-04-13, disclosed to the SEC on 2017-04-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.00 | 1,000,000 | $2.0M | 40.0% |
| 2 | $2.00 | 1,500,000 | $3.0M | 60.0% |
| Total | $2.00 avg | 2,500,000 | $5.0M | 100% |